ArticleClinical journal of gastroenterology2022

Nivolumab dose escalation triggered immune checkpoint inhibitor-induced colitis after 147 weeks of prolonged stable use in a patient with lung cancer: a case report.

Kazumasa Soma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.